Biol. Bull. Sign up for etocs!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fickbohm, D. J.
Right arrow Articles by Katz, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fickbohm, D. J.
Right arrow Articles by Katz, P. S.
Related Collections
Right arrow Imaging and Microscopy
Right arrow Molluscs
Right arrow Neuroscience
Biol. Bull. 209: 67-74. (August 2005)
© 2005 Marine Biological Laboratory

Pharmacological Manipulation of Serotonin Levels in the Nervous System of the Opisthobranch Mollusc Tritonia diomedea

David J. Fickbohm, Nadja Spitzer and Paul S. Katz{dagger}

Department of Biology, Georgia State University, P.O. Box 4010, Atlanta, Georgia 30302-4010

* Present Address: Santa Monica College, Life Sciences, 1900 Pico Boulevard, Santa Monica, California 90405. E-mail: fickbohm_david{at}smc.edu

{dagger} To whom correspondence should be addressed. E-mail: pkatz{at}gsu.edu

Serotonin-related disorders can be treated by manipulating serotonin synthesis with the serotonin precursor 5-hydroxytryptophan (5-HTP) or other pharmacological agents. The mollusc Tritonia diomedea is a model for investigating the effects of altering serotonin content on the functions of identified neurons. We used high-performance liquid chromatography and immunohistochemistry to examine the amount and localization of 5-HTP, serotonin, and the serotonin breakdown product 5-hydroxyindolacetic acid (5-HIAA) in the Tritonia brain after various pharmacological treatments. Exposure to 5-HTP (2 mM for 30 min–1 h) caused an immediate and massive increase in total 5-HTP content, which lasted more than 20 h, and the widespread appearance of 5-HTP immunoreactivity in neurons. Serotonin levels rose gradually, but only a restricted number of additional neurons displayed serotonin immunoreactivity. 5-HTP treatment also caused an increase in the total amount of 5-HIAA and the appearance of 5-HIAA immunoreactivity throughout the brain. Treatment with the synthesis cofactor tetrahydrobiopterin, the initial precursor tryptophan, or serotonin itself had no persistent effect on total serotonin content. The amino acid decarboxylase inhibitor hydroxybenzylhydrazine (NSD-1015) also had no effect on the total serotonin content, although it caused an accumulation of 5-HTP. Thus, serotonin levels in the brain of T. diomedea appear to be maintained by a homeostatic mechanism that can be disrupted by 5-HTP.

Abbreviations: AADC, aromatic amino acid decarboxylase • BH4, tetrahydrobiopterin • DSI, dorsal swim interneuron • 5- HTP, 5-hydroxytryptophan • 5-HIAA, 5-hydroxyindolacetic acid • NSD-1015, hydroxybenzylhydrazine






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Marine Biological Laboratory.